Beumer, Jan H <br/><br/>
Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jun 2008 
 - 3529-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-07-4885  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Area Under Curve<br/>Biological Availability<br/>Deoxycytidine--administration & dosage<br/>Drug Interactions<br/>Male<br/>Mice<br/>Tetrahydrouridine--administration & dosage<br/>Gemcitabine